Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Amgen Inc. Announces Q1 2025 Dividend: 2.38 Per Share Payout for Shareholders

December 16, 2024
Amgen Inc., a leading biotechnology company, recently announced its first-quarter dividend for 2025. Shareholders can expect a payout of $2.38 per share, showcasing the company's commitment to delivering value to its investors. This dividend announcement reflects Amgen's strong financial performance and its confidence in the future growth prospects. With a long history of consistently paying dividends, Amgen remains a preferred choice for investors seeking a safe and reliable stock. If you want to stay updated on the latest developments and make informed investment decisions, professionals from Stocks Prognosis can provide valuable insights into the future movement of Amgen Inc. (NASDAQ: AMGN) shares.

Find out how the AMGEN INC. rate is expected to change

Get Forecast for AMGN

Investor opinions & comments:

I'm not sure if this dividend payout is sustainable in the long run. Biotech companies can be unpredictable
— from ChrisDavis at 12-20-2024 00:37
I'm hesitant to invest in Amgen solely based on their past dividend payments. Other factors should be considered before making an investment decision
— from TylerGonzalez at 12-19-2024 21:35
I'm curious to see how this dividend announcement will impact the stock price of Amgen, it could be a good opportunity for investment
— from CashChris at 12-18-2024 14:58
This dividend payout is a clear indication of Amgen's financial strength and their commitment to rewarding their shareholders
— from LaylaFloyd at 12-18-2024 02:27
I've been a long-term investor in Amgen, and this dividend payout reaffirms my confidence in the company's growth prospects
— from MoneyMiles at 12-17-2024 20:54
It's hard to predict the future movement of stock prices, and I'm not sure if this dividend announcement will actually benefit shareholders
— from SmartSophie at 12-17-2024 15:01
With Amgen's strong track record of consistently paying dividends, I have confidence in the company's ability to generate stable returns
— from LillianBell at 12-17-2024 09:15
This is great news! I'm excited about Amgen's strong financial performance and their commitment to delivering value to shareholders
— from AlexPhillips at 12-17-2024 07:00
Amgen has been a reliable stock for me in the past, and I'm glad to see that they are continuing to prioritize delivering value to investors
— from SmartSophie at 12-16-2024 17:24
If you want to leave a comment, then you need Login or Register





Other news for AMGN

AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....

AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....

AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....

AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....

AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....



Related news

REGNJanuary 4, 2025Regeneron Pharmaceuticals Inc.: A Strong Investment Opportunity for Shareholders  ~1 min.

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) has proven to be a successful investment option for shareholders, with a decent 89% return over the last five years....

REGNJanuary 12, 2025Regeneron Pharmaceuticals Faces Shareholder Class Action Lawsuit  ~1 min.

Regeneron Pharmaceuticals, Inc., a leading biotechnology company, is currently facing a shareholder class action lawsuit....

VRTXJanuary 6, 2025Investors Should Consider Buying Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Now  ~2 min.

Vertex Pharmaceuticals Incorporated is a leading biotechnology company specializing in the discovery, development, and commercialization of innovative medicines for serious diseases....

BIIBJanuary 24, 2025Nisa Investment Advisors LLC Purchases 149461 Shares of Biogen Inc. NASDAQ:BIIB  ~1 min.

Nisa Investment Advisors LLC, a renowned investment firm, has recently made a significant investment in Biogen Inc., acquiring 149,461 shares of the company's stock....

BIIBDecember 22, 2024Stifel downgrades Biogen on slow Alzheimer's drug launch uncertainty ahead  ~2 min.

Biogen Inc., a leading biotechnology company, is facing a setback as Stifel downgrades its stock due to uncertainty surrounding the launch of its Alzheimer's drug....